Home > Boards > US Listed > Medical - Drugs > Cocrystal Pharma Inc. (COCP)

COCP: effective Jan. 24,2018 a one for 30

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Renee Member Profile
Member Level 
Followed By 1,292
Posts 27,725
Boards Moderated 6
Alias Born 07/12/04
160x600 placeholder
Cocrystal Pharma Presents Data at the 26th International Symposium on Hepatitis C Virus and Related Viruses GlobeNewswire Inc. - 10/8/2019 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/4/2019 8:31:49 AM
Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus an... GlobeNewswire Inc. - 10/1/2019 8:00:00 AM
Cocrystal Pharma to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 8:05:00 AM
Cocrystal Pharma Presents Positive Preclinical Data for CC-42344 at the Options X for the Control of Influenza Conference GlobeNewswire Inc. - 9/3/2019 8:05:00 AM
Cocrystal Pharma Announces Abstract Accepted for Oral Presentation at the ISIRV: Options X for the Control of Influenza Confe... GlobeNewswire Inc. - 8/21/2019 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 8:31:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 8:32:13 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/23/2019 6:01:32 AM
Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis... GlobeNewswire Inc. - 5/20/2019 8:05:00 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 5/15/2019 8:37:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 8:01:26 AM
Cocrystal Pharma Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/10/2019 8:35:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:32:59 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/9/2019 5:15:08 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/30/2019 3:33:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 8:31:43 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/25/2019 8:33:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 4:27:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/15/2019 4:01:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2019 4:31:37 PM
Cocrystal Pharma Reports 2018 Financial Results and Provides Corporate Overview and Business Outlook GlobeNewswire Inc. - 4/1/2019 8:35:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 8:33:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2019 5:15:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2019 5:26:31 PM
Renee Member Level  Tuesday, 01/23/18 08:49:21 AM
Re: None
Post # of 1223 
COCP: effective Jan. 24,2018 a one for 30 reverse split:

http://otce.finra.org/DLSymbolNameChanges

To bite the worm of incite is to bite the HOOK of the antagonist . They win .
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist